Carmine N. Stengone

Director & CEO and President

Director & CEO and President at Contineum Therapeutics, Inc., filing insider transactions between 2026-02-11 and 2026-02-25.

Total Purchases

—

0 transactions

Total Sales

$120K

3 transactions

Companies Traded

3 total filings

Active Since

2026-02-11

Last: 2026-02-25

Companies

Contineum Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-25	CTNM	Sale	2,700	$16.02	$43K	15.0K	SEC ↗
2026-02-24	CTNM	Sale	4,400	$16.02	$70K	15.0K	SEC ↗
2026-02-11	CTNM	Sale	400	$16.00	$6K	15.0K